SCHEDULE: Sio Capital Discloses 7.19% Stake in PMV Pharma

Sio Capital Management, LLC has reported a 7.19% beneficial ownership stake in PMV Pharmaceuticals, Inc. as of June 30, 2025.

Summary

• Sio Capital Management, LLC, an investment adviser, beneficially owns 3,735,396 shares of common stock in PMV Pharmaceuticals, Inc.
• This ownership represents 7.19% of PMV Pharmaceuticals' common stock outstanding.
• The calculation is based on 51,952,680 shares of common stock outstanding as of May 9, 2025, as reported in PMV Pharmaceuticals' Form 10-K.
• Sio Capital Management, LLC holds shared voting power and shared dispositive power over all 3,735,396 shares.
• The shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 5

Explanation: The filing is a factual disclosure of beneficial ownership and does not contain information that inherently indicates positive or negative sentiment regarding the company's performance or outlook. It is a routine regulatory update.

Future Outlook

NA

Industry Context

This filing is a routine disclosure of a significant ownership stake by an investment adviser in a publicly traded pharmaceutical company. Such disclosures provide transparency regarding institutional holdings and are common in the financial industry.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional holder's stake in the company.

Key Dates

Keywords

PMV Pharmaceuticals, Sio Capital Management, Beneficial Ownership, Common Stock, Investment Adviser, SEC Filing, Schedule 13G, Equity Stake